I serve as Senior Research and Development Scientist at AQ Biotech Ltd, Turku, where I contribute to research and development activities related to E-TRF (Enhanced Time-Resolved Fluorescence) detection systems and phage biosensor technologies for disease diagnosis. My role involves experimental design, assay development and optimization, and the translation of biosensor concepts into diagnostic applictaions.

Alongside my professional role, I am a part-time doctoral researcher whose research focuses on the development of innovative biosensing technologies for disease diagnostics. My research aims to develop phage-based biosensors capable of identifying the primary tumor origin in metastatic cancers, addressing a major challenge in oncology diagnostics where metastases are detected but the tissue of origin remains uncertain. This work integrates molecular biology, bioengineering, and diagnostic assay development to create sensitive and specific tools that can improve clinical decision-making and personalized treatment strategies.

Prior to my current work in phage-biosensor development, my research experience focused on infectious disease biology, particularly malaria. I have extensive laboratory experience in Plasmodium parasite culture, in vitro antimalarial drug inhibition assays, PCR-based malaria diagnosis, DNA extraction, malaria surveillance, and mosquito rearing and Plasmodium infectivity assays. This work provided a strong foundation in parasitology, molecular diagnostics, and host–vector–pathogen interactions.

I hold a Bachelor of Science in Biochemistry, Cell and Molecular Biology and a Master of Philosophy in Food Science. My master’s research focused on developing a process for bromelain extraction from pineapple waste, contributing to the sustainable utilization of agro-industrial by-products.

My research interests lie at the intersection of molecular diagnostics, biosensor development, biotechnology innovation, and translational disease detection technologies, with the overarching goal of advancing sensitive and accessible diagnostic tools for both infectious and non-communicable diseases.

My research aims to develop phage-based biosensors capable of identifying the primary tumour origin in metastatic cancers, addressing a major challenge in oncology diagnostics where metastases are detected but the tissue of origin remains uncertain. Identifying primary tumour origins in metastases is critical in planning treatment strategies for patients. Through this work, we hope to identify non-invasive markers for metastatic cancer diagnosis.